Allied Gaming & Entertainment Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Allied Gaming & Entertainment Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $698.5K | Mar 28, 2024 |
| FY2023 | Dec 31, 2022 | $6.35M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $4.96M | Mar 24, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($16.76M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($3.44M) | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | ($10.82M) | Mar 24, 2023 |
| FY2022 | Dec 31, 2021 | $62.87M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($45.06M) | May 26, 2022 |
| FY2020 | Dec 31, 2019 | ($16.74M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($30.62M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $93.2K | Mar 18, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($23.31M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($6.60M) | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | ($11.77M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($15.77M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($31.73M) | May 26, 2022 |
| FY2020 | Dec 31, 2019 | ($14.36M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($28.83M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($130.2K) | Mar 18, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $865.6K | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $162.9K | Jun 9, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($9.77M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($8.14M) | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | ($10.93M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($10.08M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($5.17M) | May 26, 2022 |
| FY2020 | Dec 31, 2019 | ($7.55M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($14.61M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($114.9K) | Mar 18, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $83.0K | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $378.1K | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | $44.4K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $191.7K | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $355.8K | May 26, 2022 |
| FY2020 | Dec 31, 2019 | $1.32M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $17.14M | Mar 17, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $112.69M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $112.02M | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | $97.73M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $105.80M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $61.90M | May 26, 2022 |
| FY2020 | Dec 31, 2019 | $74.70M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $65.67M | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $139.46M | Mar 18, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $35.16M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $18.61M | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | $9.83M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $7.16M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $28.49M | May 26, 2022 |
| FY2020 | Dec 31, 2019 | $30.48M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $41.65M | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $134.1K | Mar 18, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $73.01M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $82.75M | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | $87.90M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $98.65M | Mar 24, 2023 |
| FY2022 | Dec 31, 2020 | $33.41M | Mar 24, 2023 |
| FY2021 | Dec 31, 2019 | $44.22M | May 26, 2022 |
| FY2020 | Dec 31, 2018 | $24.02M | Apr 13, 2021 |
| FY2019 | Dec 31, 2017 | $12.61M | Mar 17, 2020 |
| FY2018 | May 8, 2017 | $0 | Mar 18, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.80M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $12.73M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $22.8K | Mar 24, 2023 |
| FY2022 | Dec 31, 2021 | $26.8K | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $30.8K | May 26, 2022 |
| FY2021 | Dec 31, 2019 | $34.0K | May 26, 2022 |
| FY2020 | Dec 31, 2018 | $29.7K | Apr 13, 2021 |
| FY2019 | Jan 31, 2018 | $4.34M | Mar 17, 2020 |
| FY2019 | Dec 31, 2017 | $20.28M | Mar 17, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($130.43M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($113.67M) | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | ($110.24M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($99.41M) | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | ($162.28M) | May 26, 2022 |
| FY2020 | Dec 31, 2019 | ($117.22M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($100.48M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $93.2K | Mar 18, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $59.24M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $16.32M | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | $11.17M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $92.89M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $424.2K | May 26, 2022 |
| FY2018 | Dec 31, 2018 | $133.7K | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $428.0K | Mar 18, 2019 |
| FY2018 | May 8, 2017 | $0 | Mar 18, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 44.11M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 36.81M | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | 38.50M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 39.12M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 38.51M | May 26, 2022 |
| FY2020 | Dec 31, 2019 | 23.18M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | 11.60M | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | 4.35M | Mar 18, 2019 |